Friday, July 15, 2011

Serious Gaps in US Drug Safety

Updated February 2, 2021:

Links in the original post broke.

- - -  the original post follows below  - - -

This caught my eye in the National Journal, Pew Study Finds Gaps in FDA Oversight of Imported Drugs.

In a nutshell, Pew Finds Serious Gaps in Oversight of U.S. Drug Safety points to the Pew white paper that finds that increased outsourcing of manufacturing, a complex and globalized supply chain and criminal actors create the potential for counterfeit or substandard medicines to enter the supply chain and reach patients.

No comments:

From SkillsPlus International Inc.